Clinical Microbiology Department. Hospital Universitario La Paz. Madrid, Spain.
Clinical Microbiology Department. Hospital Universitario La Paz. Madrid, Spain.
Diagn Microbiol Infect Dis. 2024 Nov;110(3):116437. doi: 10.1016/j.diagmicrobio.2024.116437. Epub 2024 Jul 15.
Endometriosis, infertility, or recurrent pregnancy loss (RPL) are entities characterised by a decrease in Lactobacillus spp. and an increase in bacterial vaginosis-associated bacteria, (BVAV) according with 16S rRNA sequencing studies. However, the use of nucleic acid amplification tests (NAAT) as a tool for diagnosis algorithms is unknown. Seventy-four patients were included, with a median age of 36.5 years old (IQR: 34-39) including infertility (n=31), endometriosis (n=25), or RPL (n=18), for culturing and NAAT using the Allplex™ Bacterial Vaginosis Plus (ABVP) assay (Seegene) with endometrial samples. The objective was determining the utility of ABVP assay for diagnosing the entities. Forty-six microorganisms were isolated from 31 out of 74 patients (41.9 %). Twenty-five endometrial samples (33.8 %) were positive for some targets included in the ABVP-assay, with median Ct value ∼37 (IQR: 31.3-37.1) and Qt value 1.43 Logcopies/reaction (IQR:1.1-2.6). For Lactobacillus species, sensitivity and specificity were 80 % and 84 %, respectively. Gardnerella vaginalis, 63.6 % and 95.7 %. No significant increase in BVAV was detected in any of the gynaecological entities. The ABVP and culture based algorithm did not show utility as a tool for endometriosis, infertility, or RPL diagnosis.
子宫内膜异位症、不孕或反复妊娠丢失 (RPL) 的特征是乳杆菌属 spp. 的减少和细菌性阴道病相关细菌 (BVAV) 的增加,这与 16S rRNA 测序研究一致。然而,核酸扩增检测 (NAAT) 是否可作为诊断算法的工具尚不清楚。共纳入 74 例患者,年龄中位数为 36.5 岁(IQR:34-39),包括不孕(n=31)、子宫内膜异位症(n=25)或 RPL(n=18),对子宫内膜样本进行培养和使用 Allplex™细菌性阴道病加(ABVP)检测(Seegene)进行 NAAT。目的是确定 ABVP 检测在诊断这些疾病中的效用。从 74 例患者中的 31 例(41.9%)中分离出 46 种微生物。25 份子宫内膜样本(33.8%)对 ABVP 检测中包含的一些靶标呈阳性,中位 Ct 值约为 37(IQR:31.3-37.1),Qt 值为 1.43 Logcopies/reaction(IQR:1.1-2.6)。乳杆菌属的敏感性和特异性分别为 80%和 84%。Gardnerella vaginalis 为 63.6%和 95.7%。在任何妇科实体中均未检测到 BVAV 的显著增加。ABVP 和基于培养的算法不能作为子宫内膜异位症、不孕或 RPL 诊断的工具。